High level MLL amplification in AML and MDS.

被引:0
|
作者
Dolan, M [1 ]
Hirsch, B [1 ]
Eckfeldt, J [1 ]
机构
[1] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
55
引用
收藏
页码:315 / 315
页数:1
相关论文
共 50 条
  • [21] AML/MDS with 11q/MLL Amplification Show Characteristic Gene Expression Signature and Interplay of DNA Copy Number Changes
    Zatkova, Andrea
    Merk, Sylvia
    Wendehack, Melanie
    Bilban, Martin
    Muzik, Eva Maria
    Muradyan, Artur
    Haferlach, Claudia
    Haferlach, Torsten
    Wimmer, Katharina
    Fonatsch, Christa
    Ullmann, Reinhard
    GENES CHROMOSOMES & CANCER, 2009, 48 (06): : 510 - 520
  • [22] Amplification of chromosome band 11q23 including the unrearranged MLL gene in therapy-related MDS and AML.
    Andersen, MK
    Christiansen, DH
    Pedersen-Bjergaard, J
    Geisler, C
    BLOOD, 1999, 94 (10) : 594A - 594A
  • [23] PSCT is a valuable therapy option in high risk primary MDS.
    Beedassy, A
    Topolsky, D
    Crilley, P
    Styler, M
    Dave, A
    Brodsky, I
    BLOOD, 1998, 92 (10) : 361B - 361B
  • [24] Impact of prior solid tumor on outcomes of allogeneic hematopoietic stem cell transplantation for AML or MDS.
    Albittar, Aya
    Portuguese, Andrew Jay
    Gooley, Ted
    Deeg, H. Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Randomized trial of idarubicin plus ARA-C +/-lisofylline in newly-disgnosed AML/MDS.
    Estey, E
    Dahlberg, S
    Kantarjian, H
    Reed, P
    Pierce, S
    MacPherson, B
    Bianco, J
    Singer, J
    Keating, M
    BLOOD, 1997, 90 (10) : 2254 - 2254
  • [26] Overworked young MDs. - Asleep on the job
    Sharfstein, JM
    NEW REPUBLIC, 1999, 220 (25) : 17 - 18
  • [27] Combined chemotherapy for patients with high risk myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS.
    Shi, J
    Shao, ZH
    Liu, H
    Chen, GB
    Zhang, YZ
    Bai, J
    He, GS
    Fu, R
    Zhao, MF
    Cao, YR
    Wu, YH
    Jing, LP
    Hao, YS
    Yang, TY
    BLOOD, 2003, 102 (11) : 13B - 13B
  • [28] Allogeneic hematopoietic stem cell transplantation (HSCT) for patients aged 65 years or older with AML and MDS.
    de Lima, M
    Shahjahan, M
    Alamo, J
    Williams, P
    von Wolff, B
    Couriel, D
    Khouri, I
    Rondon, G
    Wheeler, B
    Estey, E
    Ueno, N
    Kebriaei, P
    Champlin, R
    Giralt, S
    BLOOD, 2004, 104 (11) : 632A - 633A
  • [29] HEPATOCEREBRAL FORM OF MDS. DIAGNOSTIC DIFFICULTIES
    Tsygankova, P. G.
    Zakharova, E. Yu
    Nikolaeva, E. A.
    Degtyareva, A., V
    Itkis, Y. S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S169 - S169
  • [30] Proposal for extending the classification of adult myelodysplastic syndromes (MDS) to pediatric MDS.
    Greenberg, PL
    PEDIATRIC RESEARCH, 1999, 45 (05) : 746 - 746